Picture of Medivir AB logo

MVIR Medivir AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Medivir Obtains Ind Approval For Fostrox

Dec 16 (Reuters) - Medivir AB  MEDIVIR.ST :
    * OBTAINS IND APPROVAL FOR FOSTROX - THE FIRST ORAL,
LIVER-TARGETED TREATMENT FOR ADVANCED LIVER CANCER
    * PLANS TO RECRUIT PATIENTS IN AT LEAST 8 COUNTRIES ACROSS
USA,
EUROPE AND ASIA, AIMING FOR STUDY READ-OUT IN 2027

Source text:  ID:nMFN1kj3Cf 
Further company coverage:  MEDIVIR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

Recent news on Medivir AB

See all news